Why Intellia Therapeutics’ and Moderna’s Stocks Moved South Yesterday

Intellia Therapeutics
Intellia Therapeutics (NTLA) stock price headed south probably because some robots learned that the firm commenced an underwritten public offering of $150 million of shares of its common stock.

In addition to the commenced public offering Intellia announced its intention to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.